secwatch / observer
8-K filed March 21, 2023, 7:59 PM ET ticker HQY CIK 0001428336
earnings confidence high sentiment positive materiality 0.85

HealthEquity FY2023 revenue $861.7M (+14% YoY); guides FY2024 rev $960-975M, EBITDA $320-335M

HEALTHEQUITY, INC.

2023-FY EPS reported -$0.31 revenue$861,748,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HEALTHEQUITY, INC. reported the fiscal year ended January 31, 2023 results: revenue $861.7 million, net income Net loss of $26.1 million, EPS $0.31 per diluted share.

Period
the fiscal year ended January 31, 2023
Revenue
$861.7 million
Net income
Net loss of $26.1 million
EPS
$0.31 per diluted share
Result
reported results
Exact text from the filing
Revenue for the fiscal year ended January 31, 2023 was $861.7 million, an increase of 14% compared to $756.6 million for the fiscal year ended January 31, 2022. Revenue this year included: service revenue of $430.2 million, custodial revenue of $283.1 million, and interchange revenue of $148.4 million. HealthEquity reported a net loss of $26.1 million, or $0.31 per diluted share, and non-GAAP net income of $114.5 million, or $1.36 per diluted share, for the fiscal year ended January 31, 2023.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HEALTHEQUITY, INC. reported the fourth quarter ended January 31, 2023 results: revenue $233.8 million, net income Net loss of $0.2 million, EPS less than one cent per diluted share.

Period
the fourth quarter ended January 31, 2023
Revenue
$233.8 million
Net income
Net loss of $0.2 million
EPS
less than one cent per diluted share
Result
reported results
Exact text from the filing
Revenue for the fourth quarter ended January 31, 2023 was $233.8 million, an increase of 15% compared to $203.3 million for the fourth quarter ended January 31, 2022. Revenue this quarter included: service revenue of $114.2 million, custodial revenue of $83.5 million, and interchange revenue of $36.1 million. HealthEquity reported a net loss of $0.2 million, or less than one cent per diluted share, and non-GAAP net income of $31.3 million, or $0.37 per diluted share, for the fourth quarter ended January 31, 2023.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HEALTHEQUITY, INC. reported the fiscal year ending January 31, 2024 results: revenue $960 million to $975 million, net income between $0 and $11 million, EPS $0.00 to $0.13 per diluted share. Guidance initiated.

Period
the fiscal year ending January 31, 2024
Revenue
$960 million to $975 million
Net income
between $0 and $11 million
EPS
$0.00 to $0.13 per diluted share
Guidance
initiated
Result
guidance update
Exact text from the filing
For the fiscal year ending January 31, 2024, management expects revenues of $960 million to $975 million. Its outlook for net income is between $0 and $11 million, resulting in net income of $0.00 to $0.13 per diluted share. Its outlook for non-GAAP net income, calculated using the method described below, is between $152 million and $163 million, resulting in non-GAAP net income per diluted share of $1.74 to $1.87 (based on an estimated 87 million weighted-average shares outstanding).
View on SEC.gov

171 earnings releases filed in the last 30 days. Browse all earnings releases →

HEALTHEQUITY, INC. filing history →

Source: SEC EDGAR
accession 0001428336-23-000012
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.